Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on Capital EmployedReturn on Invested CapitalTimes Interest Earned

Lifecore Biomedical, Inc. \De\ (LFCR) EBT Margin (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported EBT Margin over the past 16 years, most recently at 3.06% for Q2 2025.

  • Quarterly results put EBT Margin at 3.06% for Q2 2025, up 1580.0% from a year ago — trailing twelve months through May 2025 was 30.01% (down 3743.0% YoY), and the annual figure for FY2025 was 30.01%, down 3743.0%.
  • EBT Margin for Q2 2025 was 3.06% at Lifecore Biomedical, Inc. \De\, up from 42.04% in the prior quarter.
  • Over the last five years, EBT Margin for LFCR hit a ceiling of 47.02% in Q4 2023 and a floor of 118.05% in Q2 2023.
  • Median EBT Margin over the past 5 years was 24.81% (2022), compared with a mean of 26.45%.
  • Biggest five-year swings in EBT Margin: crashed -10330bps in 2023 and later soared 9920bps in 2024.
  • Lifecore Biomedical, Inc. \De\'s EBT Margin stood at 4.97% in 2021, then crashed by -947bps to 42.06% in 2022, then surged by 212bps to 47.02% in 2023, then tumbled by -143bps to 20.05% in 2024, then skyrocketed by 85bps to 3.06% in 2025.
  • The last three reported values for EBT Margin were 3.06% (Q2 2025), 42.04% (Q1 2025), and 20.05% (Q4 2024) per Business Quant data.